Back

Clinical characteristics of patients with raised BNP referred from primary care to an outpatient heart failure with potential heart failure using NICE guidelines

31 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Diagnostic accuracy of natriuretic peptides Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Robert John Bain

Grimsby (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
ESC Heart Failure Association age-adjusted natriuretic peptide thresholds for a new diagnosis of heart failure: diagnostic accuracy study
Professor C. Taylor (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Screening for stage B heart failure in Type 2 diabetes: natriuretic peptide screening alone misses echocardiographic abnormalities
Doctor C. Chandramouli (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical diabetic cardiomyopathy
Doctor P. Gouda (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Exploring heart failure prevalence and overlooked dimensions: a comprehensive NT Pro-BNP study in high-risk primary care patients
Professor A. Celik (Mersin, TR)
Abstract Slides Video
Presentation thumbnail
Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
Doctor Y. Takigami (Sagamihara, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnostic accuracy of natriuretic peptides

The Event

Event poster

ESC Congress 2024

31 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Mortality of heart failure patients in the outpatient setting is significantly impacted by the source of referral - it's high time to change the paradigm
thumbnail
Congress Session
Advances in heart failure detection and therapy
thumbnail
Congress Presentation
Early initiation of disease-modifying therapy in patients with suspected heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources